• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全激酶组高通量 siRNA 筛选鉴定出 MEK5-ERK5 信号通路对乳腺癌细胞 EMT 和转移至关重要。

A kinome-wide high-content siRNA screen identifies MEK5-ERK5 signaling as critical for breast cancer cell EMT and metastasis.

机构信息

Department of Biomedicine, University of Basel, Basel, 4058, Switzerland.

出版信息

Oncogene. 2018 Aug;37(31):4197-4213. doi: 10.1038/s41388-018-0270-8. Epub 2018 May 1.

DOI:10.1038/s41388-018-0270-8
PMID:29713055
Abstract

An epithelial to mesenchymal transition (EMT) has been correlated to malignant tumor progression and metastasis by promoting cancer cell migration and invasion and chemoresistance. Hence, finding druggable EMT effectors is critical to efficiently interfere with metastasis formation and to overcome therapy resistance. We have employed a high-content microscopy screen in combination with a kinome and phosphatome-wide siRNA library to identify signaling pathways underlying an EMT of murine mammary epithelial cells and breast cancer cells. This screen identified the MEK5-ERK5 axis as a critical player in TGFβ-mediated EMT. Suppression of MEK5-ERK5 signaling completely prevented the morphological and molecular changes occurring during a TGFβ-induced EMT and, conversely, forced highly metastatic breast cancer cells into a differentiated epithelial state. Inhibition of MEK5-ERK5 signaling also repressed breast cancer cell migration and invasion and substantially reduced lung metastasis without affecting primary tumor growth. The results suggest that the MEK5-ERK5 signaling axis via activation of MEF2B and other transcription factors plays an important role in the induction and maintenance of breast cancer cell migration and invasion and thus represents an exploitable target for the pharmacological inhibition of cancer cell metastasis.

摘要

上皮间质转化 (EMT) 通过促进癌细胞迁移和侵袭以及化疗耐药性,与恶性肿瘤的进展和转移相关。因此,寻找可成药的 EMT 效应物对于有效地干扰转移形成和克服治疗耐药性至关重要。我们采用高内涵显微镜筛选结合激酶组和磷酸酶组的 siRNA 文库,鉴定了介导小鼠乳腺上皮细胞和乳腺癌细胞 EMT 的信号通路。该筛选确定了 MEK5-ERK5 轴在 TGFβ 介导的 EMT 中是一个关键的参与者。抑制 MEK5-ERK5 信号完全阻止了 TGFβ 诱导的 EMT 过程中发生的形态和分子变化,相反,将高度转移性的乳腺癌细胞强制转化为分化的上皮状态。抑制 MEK5-ERK5 信号还抑制了乳腺癌细胞的迁移和侵袭,并大大减少了肺转移,而不影响原发性肿瘤的生长。结果表明,MEK5-ERK5 信号轴通过激活 MEF2B 和其他转录因子,在诱导和维持乳腺癌细胞迁移和侵袭中发挥重要作用,因此代表了可用于抑制癌细胞转移的药理学靶点。

相似文献

1
A kinome-wide high-content siRNA screen identifies MEK5-ERK5 signaling as critical for breast cancer cell EMT and metastasis.全激酶组高通量 siRNA 筛选鉴定出 MEK5-ERK5 信号通路对乳腺癌细胞 EMT 和转移至关重要。
Oncogene. 2018 Aug;37(31):4197-4213. doi: 10.1038/s41388-018-0270-8. Epub 2018 May 1.
2
Upregulation of MEK5 by Stat3 promotes breast cancer cell invasion and metastasis.Stat3对MEK5的上调促进乳腺癌细胞的侵袭和转移。
Oncol Rep. 2017 Jan;37(1):83-90. doi: 10.3892/or.2016.5256. Epub 2016 Nov 18.
3
Proteomic analysis of tumor necrosis factor-alpha resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype.对肿瘤坏死因子-α 耐药的人乳腺癌细胞进行蛋白质组学分析,揭示了一种由MEK5/Erk5介导的上皮-间质转化表型。
Breast Cancer Res. 2008;10(6):R105. doi: 10.1186/bcr2210. Epub 2008 Dec 16.
4
MEK5/ERK5 signaling suppresses estrogen receptor expression and promotes hormone-independent tumorigenesis.MEK5/ERK5 信号通路抑制雌激素受体表达并促进激素非依赖性肿瘤发生。
PLoS One. 2013 Aug 9;8(8):e69291. doi: 10.1371/journal.pone.0069291. eCollection 2013.
5
Dual inhibition of MEK1/2 and MEK5 suppresses the EMT/migration axis in triple-negative breast cancer through FRA-1 regulation.双重抑制 MEK1/2 和 MEK5 通过 FRA-1 调控抑制三阴性乳腺癌中的 EMT/迁移轴。
J Cell Biochem. 2021 Aug;122(8):835-850. doi: 10.1002/jcb.29916. Epub 2021 Apr 20.
6
Molecular Mechanisms of Epithelial to Mesenchymal Transition Regulated by ERK5 Signaling.ERK5 信号调控的上皮间质转化的分子机制。
Biomolecules. 2021 Jan 29;11(2):183. doi: 10.3390/biom11020183.
7
Long non-coding RNAs (LncRNA) regulated by transforming growth factor (TGF) β: LncRNA-hit-mediated TGFβ-induced epithelial to mesenchymal transition in mammary epithelia.由转化生长因子(TGF)β调控的长链非编码RNA(LncRNA):LncRNA-hit介导TGFβ诱导的乳腺上皮细胞上皮-间质转化
J Biol Chem. 2015 Mar 13;290(11):6857-67. doi: 10.1074/jbc.M114.610915. Epub 2015 Jan 20.
8
MEK5/ERK5 signaling inhibition increases colon cancer cell sensitivity to 5-fluorouracil through a p53-dependent mechanism.MEK5/ERK5信号通路抑制通过p53依赖机制增加结肠癌细胞对5-氟尿嘧啶的敏感性。
Oncotarget. 2016 Jun 7;7(23):34322-40. doi: 10.18632/oncotarget.9107.
9
Foxf2 plays a dual role during transforming growth factor beta-induced epithelial to mesenchymal transition by promoting apoptosis yet enabling cell junction dissolution and migration.Foxf2 在转化生长因子 β 诱导的上皮间质转化过程中发挥双重作用,既能促进细胞凋亡,又能促进细胞连接溶解和迁移。
Breast Cancer Res. 2018 Oct 1;20(1):118. doi: 10.1186/s13058-018-1043-6.
10
miR-143 suppresses epithelial-mesenchymal transition and inhibits tumor growth of breast cancer through down-regulation of ERK5.微小RNA-143通过下调细胞外信号调节激酶5抑制上皮-间质转化并抑制乳腺癌肿瘤生长。
Mol Carcinog. 2016 Dec;55(12):1990-2000. doi: 10.1002/mc.22445. Epub 2015 Nov 30.

引用本文的文献

1
Diagnostic and Therapeutic Advances of RNAs in Precision Medicine of Gastrointestinal Tumors.RNA在胃肠道肿瘤精准医学中的诊断与治疗进展
Biomedicines. 2024 Dec 28;13(1):47. doi: 10.3390/biomedicines13010047.
2
Bone and Extracellular Signal-Related Kinase 5 (ERK5).骨和细胞外信号调节激酶 5(ERK5)。
Biomolecules. 2024 May 4;14(5):556. doi: 10.3390/biom14050556.
3
The CoREST repressor complex mediates phenotype switching and therapy resistance in melanoma.CoREST 抑制复合物介导黑色素瘤的表型转换和治疗抵抗。

本文引用的文献

1
The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer.EMT 激活物 Zeb1 是细胞可塑性的关键因素,并促进胰腺癌转移。
Nat Cell Biol. 2017 May;19(5):518-529. doi: 10.1038/ncb3513. Epub 2017 Apr 17.
2
EMT, cell plasticity and metastasis.EMT、细胞可塑性与转移。
Cancer Metastasis Rev. 2016 Dec;35(4):645-654. doi: 10.1007/s10555-016-9648-7.
3
p21(WAF1) Mediates Cell-Cycle Inhibition, Relevant to Cancer Suppression and Therapy.p21(WAF1)介导细胞周期抑制,与癌症抑制和治疗相关。
J Clin Invest. 2024 Feb 1;134(6):e171063. doi: 10.1172/JCI171063.
4
MEK5-ERK5 Axis Promotes Self-renewal and Tumorigenicity of Glioma Stem Cells.MEK5-ERK5 轴促进神经胶质瘤干细胞的自我更新和致瘤性。
Cancer Res Commun. 2023 Jan 30;3(1):148-159. doi: 10.1158/2767-9764.CRC-22-0243. eCollection 2023 Jan.
5
The ERK5/NF-κB signaling pathway targets endometrial cancer proliferation and survival.ERK5/NF-κB 信号通路靶向子宫内膜癌的增殖和存活。
Cell Mol Life Sci. 2022 Sep 19;79(10):524. doi: 10.1007/s00018-022-04541-6.
6
ERK5 Is a Major Determinant of Chemical Sarcomagenesis: Implications in Human Pathology.ERK5是化学性肉瘤发生的主要决定因素:对人类病理学的启示。
Cancers (Basel). 2022 Jul 19;14(14):3509. doi: 10.3390/cancers14143509.
7
BAY-885, a mitogen-activated protein kinase kinase 5 inhibitor, induces apoptosis by regulating the endoplasmic reticulum stress/Mcl-1/Bim pathway in breast cancer cells.BAY-885,一种丝裂原活化蛋白激酶激酶 5 抑制剂,通过调节乳腺癌细胞内质网应激/Mcl-1/Bim 通路诱导细胞凋亡。
Bioengineered. 2022 May;13(5):12888-12898. doi: 10.1080/21655979.2022.2078557.
8
NCAPD2 promotes breast cancer progression through E2F1 transcriptional regulation of CDK1.NCAPD2 通过 E2F1 对 CDK1 的转录调控促进乳腺癌进展。
Cancer Sci. 2023 Mar;114(3):896-907. doi: 10.1111/cas.15347. Epub 2022 Dec 25.
9
Clinical Significance and Regulation of ERK5 Expression and Function in Cancer.癌症中ERK5表达与功能的临床意义及调控
Cancers (Basel). 2022 Jan 11;14(2):348. doi: 10.3390/cancers14020348.
10
ERK5 signalling pathway is a novel target of sorafenib: Implication in EGF biology.ERK5 信号通路是索拉非尼的一个新靶点:对 EGF 生物学的影响。
J Cell Mol Med. 2021 Nov;25(22):10591-10603. doi: 10.1111/jcmm.16990. Epub 2021 Oct 16.
Cancer Res. 2016 Sep 15;76(18):5189-91. doi: 10.1158/0008-5472.CAN-16-2055.
4
Epithelial-mesenchymal transition (EMT) and metastasis: yes, no, maybe?上皮-间质转化(EMT)与转移:是,否,还是有可能?
Curr Opin Cell Biol. 2016 Dec;43:7-13. doi: 10.1016/j.ceb.2016.06.002. Epub 2016 Jun 29.
5
Regulating Rho GTPases and their regulators.调节 Rho GTPases 及其调节因子。
Nat Rev Mol Cell Biol. 2016 Aug;17(8):496-510. doi: 10.1038/nrm.2016.67. Epub 2016 Jun 15.
6
Enrichr: a comprehensive gene set enrichment analysis web server 2016 update.Enrichr:一个全面的基因集富集分析网络服务器2016年更新版。
Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7. doi: 10.1093/nar/gkw377. Epub 2016 May 3.
7
A high-content EMT screen identifies multiple receptor tyrosine kinase inhibitors with activity on TGFβ receptor.一项高内涵上皮-间质转化筛选鉴定出多种对转化生长因子β受体有活性的受体酪氨酸激酶抑制剂。
Oncotarget. 2016 May 3;7(18):25983-6002. doi: 10.18632/oncotarget.8418.
8
The Reactome pathway Knowledgebase.Reactome通路知识库。
Nucleic Acids Res. 2016 Jan 4;44(D1):D481-7. doi: 10.1093/nar/gkv1351. Epub 2015 Dec 9.
9
Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance.上皮-间质转化并非肺转移所必需,但会导致化疗耐药。
Nature. 2015 Nov 26;527(7579):472-6. doi: 10.1038/nature15748. Epub 2015 Nov 11.
10
Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer.上皮-间质转化对胰腺癌转移并非必需,但可诱导其产生化疗耐药性。
Nature. 2015 Nov 26;527(7579):525-530. doi: 10.1038/nature16064. Epub 2015 Nov 11.